Patents by Inventor Bing Yao

Bing Yao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080253726
    Abstract: An optical fiber which, at an optical fiber connecting end having a plurality of voids around the periphery of a core, has a light-permeable substance, such as a resin or glass whose refractive index is lower than that of quartz type substances, filled in the voids adjacent to the connecting end. An optical fiber connecting section where an optical fiber having a plurality of voids in a clad around the periphery of a core is connected to another optical fiber, wherein the optical fiber is connected end-to-end to aforesaid another optical fiber through a refractive index matching agent whose refractive index at the minimum temperature in actual use is lower than that of the core.
    Type: Application
    Filed: March 5, 2008
    Publication date: October 16, 2008
    Applicants: HITACHI CABLE, LTD., NIPPON TELEGRAPH AND TELEPHONE CORPORATION
    Inventors: Yoshinori Kurosawa, Bing Yao, Kazumasa Ohsono, Masao Tachikura, Hisanori Nakai, Toshio Kurashima, Eiji Araki, Katumi Hiramatu
  • Publication number: 20080192778
    Abstract: A cladding is provided at an outer periphery of a solid-core doped with rare earth ions, and a metal layer is formed to be adjacent to the cladding to provide an optical fiber for a fiber laser device. The metal layer having an inner metal layer and an outer metal layer is disposed along an entire length of the optical fiber for a fiber laser device. An exciting light is incident to the optical fiber for a fiber laser device, and the exciting light is reflection-excited to emit a high power laser oscillation light. A monitoring current is constantly flown into the metal layer. When the disconnection of the optical fiber for a fiber laser device is detected based on the monitoring current, the energization of the optical fiber for a fiber laser device is stopped.
    Type: Application
    Filed: December 3, 2007
    Publication date: August 14, 2008
    Applicant: HITACHI CABLE, LTD.
    Inventors: Kazumasa Ohsono, Akihito Hongo, Seiji Kojima, Bing Yao
  • Patent number: 7376315
    Abstract: An optical fiber which, at an optical fiber connecting end having a plurality of voids around the periphery of a core, has a light-permeable substance, such as a resin or glass whose refractive index is lower than that of quartz type substances, filled in the voids adjacent to the connecting end. An optical fiber connecting section where an optical fiber having a plurality of voids in a clad around the periphery of a core is connected to another optical fiber, wherein the optical fiber is connected end-to-end to aforesaid another optical fiber through a refractive index matching agent whose refractive index at the minimum temperature in actual use is lower than that of the core.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: May 20, 2008
    Assignees: Hitachi Cable, Ltd., Nippon Telegraph and Telephone Corp.
    Inventors: Yoshinori Kurosawa, Bing Yao, Kazumasa Ohsono, Masao Tachikura, Hisanori Nakai, Toshio Kurashima, Eiji Araki, Katumi Hiramatu
  • Patent number: 7332498
    Abstract: A method of modulating KSP kinesin activity in vitro comprising contacting KSP kinesin with at least one chemical entity chosen from compounds represented by Formula I: and pharmaceutically acceptable salts thereof, where the variables are as defined further herein.
    Type: Grant
    Filed: November 23, 2005
    Date of Patent: February 19, 2008
    Assignees: Cytokinetics, Inc., SmithKline Beecham Corporation
    Inventors: Pu-Ping Lu, David J. Morgans, Jr., Bing Yao, Dashyant Dhanak, Steven David Knight
  • Publication number: 20080021050
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders, for example, by modulating the activity of KSP, are disclosed.
    Type: Application
    Filed: March 12, 2007
    Publication date: January 24, 2008
    Inventors: Gustave Bergnes, Whitney Smith, Bing Yao, David Morgans, Andrew McDonald
  • Publication number: 20070197481
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: May 6, 2005
    Publication date: August 23, 2007
    Inventors: Xiangping Qian, Andrew McDonald, Han-Jie Zhou, Luke Ashcraft, Bing Yao, Hong Jiang, Jennifer Kuo Chen Huang, Jianchao Wang, David Morgans, Bradley Morgan, Gustave Bergnes, Dashyant Dhanak, Steven Knight, Nicholas Adams, Cynthia Parrish, Kevin Duffy, Duke Fitch, Rosanna Tedesco
  • Publication number: 20070189340
    Abstract: To provide a low-cost, high reliability and high-powered operation enabled optical fiber laser, in the optical fiber laser for oscillating a laser light by introducing an excitation light for exciting the rare earth elements into the optical fiber doped partially by the rare earth elements, the optical fiber is wrapped around the base member, and one part of the outer circumferential area of the wrapped optical fiber is processed in order to form a flat surface, and one face of the prism is made contacted to the flat surface, and the excitation light is introduced to another surface of the prism.
    Type: Application
    Filed: February 5, 2007
    Publication date: August 16, 2007
    Inventors: Akihito Hongo, Kazumasa Ohsono, Bing Yao
  • Publication number: 20070149516
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: November 8, 2006
    Publication date: June 28, 2007
    Inventors: Xiangping Qian, Luke Ashcraft, Jianchao Wang, Bing Yao, Hong Jiang, Gustave Bergnes, Bradley Morgan, David Morgans, Dashyant Dhanak, Steven Knight, Nicholas Adams, Cynthia Parrish, Kevin Duffy, Duke Fitch, Rosanna Tedesco
  • Patent number: 7211580
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders, for example, by modulating the activity of KSP, are disclosed.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: May 1, 2007
    Assignee: Cytokinetics, Incorporated
    Inventors: Gustave Bergnes, Whitney W. Smith, Bing Yao, David J. Morgans, Jr., Andrew MacDonald
  • Publication number: 20060247289
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: November 9, 2005
    Publication date: November 2, 2006
    Inventors: Xiangping Qian, Andrew McDonald, Han-Jie Zhou, Luke Ashcraft, Bing Yao, Hong Jiang, Jennifer Kuo Chen Huang, Jianchao Wang, David Morgans, Bradley Morgan, Gustave Bergnes, Dashyant Dhanak, Steven Knight, Nicholas Adams, Cynthia Parrish, Kevin Duffy, Duke Fitch, Rosanna Tedesco
  • Publication number: 20060204195
    Abstract: An optical fiber which, at an optical fiber connecting end having a plurality of voids around the periphery of a core, has a light-permeable substance, such as a resin or glass whose refractive index is lower than that of quartz type substances, filled in the voids adjacent to the connecting end. An optical fiber connecting section where an optical fiber having a plurality of voids in a clad around the periphery of a core is connected to another optical fiber, wherein the optical fiber is connected end-to-end to aforesaid another optical fiber through a refractive index matching agent whose refractive index at the minimum temperature in actual use is lower than that of the core.
    Type: Application
    Filed: June 30, 2004
    Publication date: September 14, 2006
    Inventors: Yoshinori Kurosawa, Bing Yao, Kazumasa Ohsono, Masao Tachikura, Hisanori Nakai, Toshio Kurashima, Eiji Araki, Katumi Hiramatu
  • Publication number: 20060111374
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: November 23, 2005
    Publication date: May 25, 2006
    Inventors: Pu-Ping Lu, David Morgans, Bing Yao, Dashyant Dhanak, Steven Knight
  • Publication number: 20060094708
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: May 3, 2005
    Publication date: May 4, 2006
    Inventors: Xiangping Qian, Andrew McDonald, Han-Jie Zhou, Luke Ashcraft, Bing Yao, Hong Jiang, Jennifer Chen Huang, Jianchao Wang, David Morgans, Bradley Morgan, Gustave Bergnes, Dashyant Dhanak, Steven Knight, Nicholas Adams, Cynthia Parrish
  • Patent number: 7038048
    Abstract: Provided herein are certain compounds of Formula I: that can be used to treat diseases of proliferating cells. The compounds are KSP kinesin inhibitors, particularly inhibitors of human KSP.
    Type: Grant
    Filed: May 22, 2003
    Date of Patent: May 2, 2006
    Assignees: Cytokinetics, Inc., SmithKline Beecham Corporation
    Inventors: Pu-Ping Lu, David J. Morgans, Jr., Bing Yao, Dashyant Dhanak, Steven David Knight
  • Publication number: 20040192913
    Abstract: Racemates are obtained from one of the enantiomers, or an enantiomerically enriched mixture, of an optically active quinazolinone derivative by reaction of the compound with an alkali alkoxide of a primary alcohol and isolation of the racemate.
    Type: Application
    Filed: February 6, 2004
    Publication date: September 30, 2004
    Applicant: CYTOKINETICS, INC.
    Inventors: Gustave Bergnes, Bing Yao, David Morgans, Whitney W. Smith
  • Publication number: 20040142949
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders, for example, by modulating the activity of KSP, are disclosed.
    Type: Application
    Filed: July 23, 2003
    Publication date: July 22, 2004
    Inventors: Gustave Bergnes, Whitney W. Smith, Bing Yao, David J. Morgans, Andrew McDonald
  • Patent number: 6753428
    Abstract: Racemates are obtained from one of the enantiomers, or an enantiomerically enriched mixture, of an optically active quinazolinone derivative by reaction of the compound with an alkali alkoxide of a primary alcohol and isolation of the racemate.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: June 22, 2004
    Assignee: Cytokinetics, Inc.
    Inventors: Gustave Bergnes, Bing Yao, David Morgans, Jr., Whitney W. Smith
  • Publication number: 20040116438
    Abstract: Compounds, compositions and methods useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: May 22, 2003
    Publication date: June 17, 2004
    Inventors: Pu-Ping Lu, David J. Morgans, Bing Yao, Dashyant Dhanak, Steven David Knight
  • Publication number: 20030166933
    Abstract: Racemates are obtained from one of the enantiomers, or an enantiomerically enriched mixture, of an optically active quinazolinone derivative by reaction of the compound with an alkali alkoxide of a primary alcohol and isolation of the racemate.
    Type: Application
    Filed: November 20, 2002
    Publication date: September 4, 2003
    Inventors: Gustave Bergnes, Bing Yao, David Morgans,, Whitney W. Smith
  • Publication number: 20030009741
    Abstract: A method for development of a business process software application which comprises an action object for causing a computer system to implement an activity of a business process. The method comprises the steps of: storing a plurality of business objects, receiving a first description of a flow of the business objects, and generating the action object by combining the business objects according to the first description.
    Type: Application
    Filed: November 26, 2001
    Publication date: January 9, 2003
    Inventors: Tsung-Wei Tu, Han-Chao Lee, Bing-Yao Liao, Yu-Feng Hsieh